AQR CAPITAL MANAGEMENT LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1167557
Greenwich, CT
Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,143,020
+$17,952,880 QoQ
Shares Held
2,214,302
+403.1% QoQ
Ownership
0.867%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $1,405,033,456 across 42 Drug Manufacturers - Specialty & Generic names. BCRX ranks #10 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
3,818,037 | $643,491,951 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
546,002 | $295,840,259 | |
| 3 | ZTS |
Zoetis Inc.
|
1,070,929 | $76,956,955 | |
| 4 | VTRS |
Viatris Inc
|
4,694,966 | $74,556,056 | |
| 5 | PRGO |
PERRIGO Co plc
|
3,480,666 | $36,164,117 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
261,250 | $28,983,071 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
6,465,921 | $27,221,524 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,525,686 | $24,456,745 |
All Filings in BCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,143,020 | 2,214,302 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,190,140 | 440,141 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $5,493,467 | 704,291 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $7,588,365 | 999,785 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $10,293,192 | 1,148,794 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $9,010,867 | 1,201,449 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $6,311,339 | 839,274 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,982,923 | 787,227 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,357,228 | 543,241 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $2,323,438 | 457,370 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $2,239,923 | 373,944 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $520,500 | 73,517 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $268,139 | 38,088 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $324,492 | 38,908 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $286,908 | 24,992 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $284,256 | 22,560 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $316,521 | 29,917 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $921,600 | 56,679 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,369,266 | 98,864 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,869,149 | 130,073 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,706,231 | 107,921 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $624,295 | 61,386 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $464,477 | 62,346 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $356,992 | 103,777 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $564,597 | 118,613 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $41,738 | 20,869 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||